CytoMed Therapeutics Limited
General ticker "GDTC" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $20.7M (TTM average)
CytoMed Therapeutics Limited does not follow the US Stock Market performance with the rate: -29.1%.
Estimated limits based on current volatility of 8.9%: low 1.15$, high 1.37$
Factors to consider:
- Total employees count: 28 as of 2022
Short-term GDTC quotes
Long-term GDTC plot
Financial data
| YTD | 2024-12-31 | 2025-12-31 |
|---|---|---|
| Operating Revenue | $0.05MM | $0.25MM |
| Operating Expenses | $2.68MM | $3.76MM |
| Operating Income | $-2.63MM | $-3.52MM |
| Non-Operating Income | $0.74MM | $0.46MM |
| Interest Expense | $0.02MM | $0.02MM |
| R&D Expense | $1.43MM | $1.70MM |
| Income(Loss) | $-1.89MM | $-3.06MM |
| Profit(Loss)* | $-1.88MM | $-3.05MM |
| Stockholders Equity | $6.57MM | $6.54MM |
| Inventory | $0.61MM | $0.00MM |
| Assets | $7.37MM | $7.98MM |
| Operating Cash Flow | $-1.69MM | $-3.70MM |
| Capital expenditure | $1.03MM | $0.70MM |
| Investing Cash Flow | $0.49MM | $0.93MM |
| Financing Cash Flow | $-0.03MM | $0.21MM |
| Earnings Per Share** | $-0.16 | $-0.26 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.